MuscleMeat

Semaglutide / Ozempic (1 bezoeker)

Bezoekers in dit topic

Was zelf ook van plan lage dosis te doen. Merk je impact op trainen of kan je nog wel knallen en spier behouden?
Het is niet dat je niet kan eten, je hebt gewoon geen honger. Maar je merkt duidelijk dat je soms te weinig kcal binnen hebt tijdens trainen en je tegen een hypo aanzit, en ik vind dat ik sneller moe ben overdag. Ik krijg het dan ook voorgeschreven voor prediabetes, mijn suikerspiegel schommelt veel te hard. Eerst had ik metformin maar dat kwam met stevige bijeffecten qua trainen.
 
Maar je merkt duidelijk dat je soms te weinig kcal binnen hebt tijdens trainen en je tegen een hypo aanzit, en ik vind dat ik sneller moe ben overdag.
Dit is toch niet anders dan een normale cut of prep en toch ook logisch want je eet minder.
 
Dit is toch niet anders dan een normale cut of prep en toch ook logisch want je eet minder.
Enige verschil is denk ik dat meeste mensen veel stims nemen in cut die energie beetje helpen. Gezien je hier misselijk van kan worden zal je stims ook moeten beperken. Ga het gewoon op lage dosis proberen en zien wat er gebeurd
 
Enige verschil is denk ik dat meeste mensen veel stims nemen in cut die energie beetje helpen. Gezien je hier misselijk van kan worden zal je stims ook moeten beperken. Ga het gewoon op lage dosis proberen en zien wat er gebeurd
Iedereen moet het zelf weten natuurlijk ik zelf zie het nut van dit middel niet echt voor recreatief wat cutten.

Voor serieuze obesitas patiënten ism en mensen die dit middel daadwerkelijk nodig hebben zie ik het nut wel.
 
Dit is toch niet anders dan een normale cut of prep en toch ook logisch want je eet minder.
Klopt, maar met een incretin-memetic gaat je suikerspiegel sneller naar beneden. Dit voel ik tijdens training nu dat als ik niet of weinig carbs eet, ik altijd tegen een suikerklop aanzit. Tegen anders was fasted training geen probleem omdat ik die redelijk hoge fasted bloodglucose had.

Dus het is een beetje zoeken hoe en wanneer toch te eten als je nog degelijk wil trainen, en de dosering niet te hoog te zetten.
 
  • Like
Waarderingen: vntl
Het is een nutteloze hype voor onze doelgroep als je geen medische noodzaak hebt. Net als velen zomaar ladingen insuline nemen, zonder enige meting van je suiker. Je moet er zelf achter komen, dat is vaak de beste leermeester.
 
iemand ervaring me berberine? of die er wat meer wetenschappelijk onderbouwd kan over zeggen?
 
iemand ervaring me berberine? of die er wat meer wetenschappelijk onderbouwd kan over zeggen?
Imanshahidi M et al. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. 2019;33(3):504-523. Neag MA et al. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557. Dhamgaye S et al. Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS ONE 2014;9(8):e104554. Jiang X et al. Berberine combined with triple therapy versus triple therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:8716910. Hawrelak J. Giardiasis: pathophysiology and management. Altern Med Rev. 2003;8(2):129-42. Feng X et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923-1951. DiNicolantonio JJ et al. Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome. Open Heart. 2019;6:e000977. Zheng H et al. Antimicrobial natural product berberine is efficacious for the treatment of atrial fibrillation. Biomed Res Int. 2017;2017:3146791. Zeng XH et al. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92(2):173-176. Liu DQ et al. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies. Pharmacol Res. 2019;148:104385. Cicero AFG et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017;13(5):965-1005. Koppen LM et al. Efficacy of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968. Zhu X et al. The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease. Molecules. 2016;21(10). Li N et al. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cell. Eur J Pharm Sci. 2010;40:1-8. Habtemariam S. Berberine and inflammatory bowel disease: a concise review. Pharmacol Res. 2016;113(A):592-599. Chen C et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res. 2015;29(11):1822-7. Fan D et al. Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential. Curr Neuropharmacol. 2019;17(6):563-579. Zou K et al. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2017;38(2):157-167. An Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014;80(3):425-31. Li G et al. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol. 2010;27:919-925. Rauf A et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules. 2021;26(23):7368. Xu J et al. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 2019;19:589. Zhang J et al. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med. 2013;17(11):1484-93. Ye Y et al. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12:653887. Guo J et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610. Shabani E et al. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats. BMC Complement Med Ther. 2021;21(1):301. Mohammadian Haftcheshmeh S et al. Berberine as a promising natural compound for the treatment of periodontal disease: a focus on anti-inflammatory properties. J Cell Mol Med. 2021;25(24):11333-11337. Rui R et al. Effects of berberine on atherosclerosis. Front Pharmacol. 2021;12:764175.
 
Imanshahidi M et al. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. 2019;33(3):504-523. Neag MA et al. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557. Dhamgaye S et al. Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS ONE 2014;9(8):e104554. Jiang X et al. Berberine combined with triple therapy versus triple therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:8716910. Hawrelak J. Giardiasis: pathophysiology and management. Altern Med Rev. 2003;8(2):129-42. Feng X et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923-1951. DiNicolantonio JJ et al. Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome. Open Heart. 2019;6:e000977. Zheng H et al. Antimicrobial natural product berberine is efficacious for the treatment of atrial fibrillation. Biomed Res Int. 2017;2017:3146791. Zeng XH et al. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92(2):173-176. Liu DQ et al. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies. Pharmacol Res. 2019;148:104385. Cicero AFG et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017;13(5):965-1005. Koppen LM et al. Efficacy of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968. Zhu X et al. The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease. Molecules. 2016;21(10). Li N et al. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cell. Eur J Pharm Sci. 2010;40:1-8. Habtemariam S. Berberine and inflammatory bowel disease: a concise review. Pharmacol Res. 2016;113(A):592-599. Chen C et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res. 2015;29(11):1822-7. Fan D et al. Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential. Curr Neuropharmacol. 2019;17(6):563-579. Zou K et al. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2017;38(2):157-167. An Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014;80(3):425-31. Li G et al. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol. 2010;27:919-925. Rauf A et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules. 2021;26(23):7368. Xu J et al. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 2019;19:589. Zhang J et al. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med. 2013;17(11):1484-93. Ye Y et al. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12:653887. Guo J et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610. Shabani E et al. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats. BMC Complement Med Ther. 2021;21(1):301. Mohammadian Haftcheshmeh S et al. Berberine as a promising natural compound for the treatment of periodontal disease: a focus on anti-inflammatory properties. J Cell Mol Med. 2021;25(24):11333-11337. Rui R et al. Effects of berberine on atherosclerosis. Front Pharmacol. 2021;12:764175.
you had me at Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cell
 
you had me at Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cell
Ik spreek geen Engels, was mijn 1e hit op Google. Copy-paste
 
Voor degene die er geen zak van begrijpt, het zijn onderzoeken

Effects of Berberine on Atherosclerosis​


Berberine and barberry (Berberis vulgaris): A clinical review​


enz.

online is zelfstandig veel te vinden, soms niet wat je wilt horen
Imanshahidi M et al. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. 2019;33(3):504-523. Neag MA et al. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557. Dhamgaye S et al. Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS ONE 2014;9(8):e104554. Jiang X et al. Berberine combined with triple therapy versus triple therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:8716910. Hawrelak J. Giardiasis: pathophysiology and management. Altern Med Rev. 2003;8(2):129-42. Feng X et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923-1951. DiNicolantonio JJ et al. Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome. Open Heart. 2019;6:e000977. Zheng H et al. Antimicrobial natural product berberine is efficacious for the treatment of atrial fibrillation. Biomed Res Int. 2017;2017:3146791. Zeng XH et al. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92(2):173-176. Liu DQ et al. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies. Pharmacol Res. 2019;148:104385. Cicero AFG et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017;13(5):965-1005. Koppen LM et al. Efficacy of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968. Zhu X et al. The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease. Molecules. 2016;21(10). Li N et al. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cell. Eur J Pharm Sci. 2010;40:1-8. Habtemariam S. Berberine and inflammatory bowel disease: a concise review. Pharmacol Res. 2016;113(A):592-599. Chen C et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res. 2015;29(11):1822-7. Fan D et al. Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential. Curr Neuropharmacol. 2019;17(6):563-579. Zou K et al. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2017;38(2):157-167. An Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014;80(3):425-31. Li G et al. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol. 2010;27:919-925. Rauf A et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules. 2021;26(23):7368. Xu J et al. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 2019;19:589. Zhang J et al. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med. 2013;17(11):1484-93. Ye Y et al. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12:653887. Guo J et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610. Shabani E et al. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats. BMC Complement Med Ther. 2021;21(1):301. Mohammadian Haftcheshmeh S et al. Berberine as a promising natural compound for the treatment of periodontal disease: a focus on anti-inflammatory properties. J Cell Mol Med. 2021;25(24):11333-11337. Rui R et al. Effects of berberine on atherosclerosis. Front Pharmacol. 2021;12:764175.
 
Eli Lilly is al bezig met de volgende ronde, retatrutide. Zou nog beter werken.
 
Back
Naar boven